ArticleBioengineering (Basel, Switzerland)2026
Apilarnil Improves Early Histological Repair and Biomechanical Strength During Experimental Femoral Fracture Healing in Rats.
Article in Bioengineering (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Fracture healing remains a major challenge in orthopedic practice, and natural bioactive products have attracted increasing interest as supportive agents for bone regeneration. Apilarnil (drone larvae homogenate), a bee-derived natural product with antioxidant and anti-inflammatory properties, has not previously been investigated in fracture healing. This study evaluated the effects of oral apilarnil on experimental femoral fracture healing in rats. Forty-two male Wistar Albino rats underwent standardized closed femoral fracture fixation with intramedullary Kirschner wire stabilization and were randomly assigned to either a control group or an apilarnil-treated group receiving 400 mg/kg/day orally. Animals were sacrificed on postoperative days 15, 30, and 45. Fracture healing was assessed radiologically using the Lane and Sandhu scoring system, histopathologically using the Huo scoring system, and biomechanically by a three-point bending test. Histopathological scores were significantly higher in the apilarnil group on postoperative day 15 (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.